Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chia

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Injury|July 25, 2016
Thrombocytosis in splenic trauma: In-hospital course and association with venous thromboembolismTze L Chia, Tyler R Chesney, David Isa, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Clinical-radiological features and diagnostic modalities for mediastinal melioidosisL E Nyanti, S S Y Lee, V Shanmugam, et al.
Biomolecules|January 23, 2024
Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired CohortRachel S L Chia, Karolina Minta, Liu-Yun Wu, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Nature Communications|February 17, 2022
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesKarama Asleh, Gian Luca Negri, Sandra E Spencer Miko, et al.
Breast Cancer Research and Treatment|June 14, 2014
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY studyMark J Clemons, Brandy Cochrane, Gregory R Pond, et al.
Biochemical Pharmacology|May 18, 2026
Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementiaXiaoxue Ouyang, Rachel S L Chia, Yuek Ling Chai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2012
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenA Prat, J S Parker, C Fan, et al.
Clinical and Experimental Immunology|April 8, 2017
Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in SingaporeH S Howe, B Y H Thong, K O Kong, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Injury|July 25, 2016
Thrombocytosis in splenic trauma: In-hospital course and association with venous thromboembolismTze L Chia, Tyler R Chesney, David Isa, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Clinical-radiological features and diagnostic modalities for mediastinal melioidosisL E Nyanti, S S Y Lee, V Shanmugam, et al.
Biomolecules|January 23, 2024
Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired CohortRachel S L Chia, Karolina Minta, Liu-Yun Wu, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Nature Communications|February 17, 2022
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesKarama Asleh, Gian Luca Negri, Sandra E Spencer Miko, et al.
Breast Cancer Research and Treatment|June 14, 2014
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY studyMark J Clemons, Brandy Cochrane, Gregory R Pond, et al.
Biochemical Pharmacology|May 18, 2026
Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementiaXiaoxue Ouyang, Rachel S L Chia, Yuek Ling Chai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2012
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenA Prat, J S Parker, C Fan, et al.
Clinical and Experimental Immunology|April 8, 2017
Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in SingaporeH S Howe, B Y H Thong, K O Kong, et al.
Pageof 28